MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Levosulpiride and Movement Disorders–A Growing Concern

    D. Radhakrishnan, S. Gomathy, R. Rajan, A. Srivastava, A. Das, A. Agarwal, A. Pandit, V. Goyal (New Delhi, India)

    Objective: To describe a series of patients with levosulpiride (LVS) induced movement disorders (LIM) evaluated at a single movement disorder center, the All India Institute…
  • 2022 International Congress

    Embodied language in Parkinson disease: the case of demonstrative

    C. Giacobbe, Y. Coello, G. Santangelo (Caserta, Italy)

    Objective: Action language is recognized as impaired in Parkinson's disease (PD), proposing a functional role for the motor system in understanding action words [1]. This…
  • 2022 International Congress

    Electrophysiologic and Kinematic characterization of degenerative cerebellar ataxia

    J. Ganguly, O. Samotus, Y. Tamilselvam, Y. Mahdi, M. Tuesta, D. Aur, M. Jog (London, Canada)

    Objective: To characterize degenerative cerebellar ataxia by measuring quantitative electrophysiology, upper limb kinematics and gait. Background: Loss of cerebellar brain inhibition (CBI) in ataxia leads…
  • 2022 International Congress

    Comparing duodenal levodopa infusion based on length of treatment in advanced Parkinson’s.

    J. Alonso Maroto, E. Casas Peña, I. Muro García, M. Domínguez Gallego, E. Valiente Gordillo, L. López Manzanares, JA. Vivancos Mora (Madrid, Spain)

    Objective: In this study we seek to compare characteristics and complications of patients suffering from advanced Parkinson's treated with duodenal levodopa infusion. Background: Motor fluctuations…
  • 2022 International Congress

    RE-EMERGENT TREMOR IN ESSENTIAL TREMOR; A PLUS SIGN FOR ET PLUS ?

    E. Sanesteban Beceiro, P. Mayo Rodríguez, A. Fernández Revuelta, V. Gómez Mayordomo, E. López Valdés, R. García-Ramos, F. Alonso Frech (Madrid, Spain)

    Objective: This study aimed to investigate whether re-emergent tremor (RET) might also occur in essential tremor (ET) and if the cases with this additional sign…
  • 2022 International Congress

    Widening the phenotype of FXTAS in females: Spasmodic dysphonia in two patients

    S. Khan, S. Williams, J. Cosgrove, J. Bamford, J. Alty (Leeds, United Kingdom)

    Objective: We present the cases of two female FXTAS patients who both developed spasmodic dysphonia (SD), also known as laryngeal dystonia. Background: Fragile-X-associated tremor/ataxia syndrome…
  • 2022 International Congress

    Increased Neutrophil to Lymphocyte Ratio Distinguish Parkinson’s Disease and Parkinson Plus Syndrome

    IH. Kwak, HI. Ma, YE. Kim (Anyang, Republic of Korea)

    Objective: To investigate the peripheral inflammatory markers distinguishing Parkinson’s disease (PD) or Parkinson plus syndrome (PPS). Background: Previous studies had suggested that peripheral inflammation may…
  • 2022 International Congress

    KMT2B episignature analysis identifies a probably hypomorphic missense variant in a family with dystonic and non-dystonic phenotypes

    S. Siegert, W. Schmidt, M. Freilinger, J. Winkelmann, N. Mirza-Schreiber, K. Oexle, M. Zech (Vienna, Austria)

    Objective: Recently, DNA methylation episignature analysis has been introduced as a tool enabling re-classification of “variants of uncertain significance“ (VUS) in lysine-specific methyltransferase 2B (KMT2B),…
  • 2022 International Congress

    Paroxysmal dystonia with phenotypic variability in ECHS1 mutation twin carriers

    G. Bonato, M. Nosadini, S. Andretta, A. Suppiej, A. Leon, S. Sartori, M. Carecchio (Padua, Italy)

    Objective: To describe 2 monozygotic twins carrying biallelic ECHS1 mutations with different clinical phenotypes Background: ECHS1 encodes for a mitochondrial short chain enoyl-CoA hydratase, a…
  • 2022 International Congress

    Social cognition in Parkinson’s disease

    G. Siripurapu, R. Rajan, D. M R, E. A, A. Gupta, V. V Y, M. Singh, R. Bhatia, M. Tripathi, A. Srivastava, M. Srivastava, B. Verma, D. Biswas (NEW DELHI, India)

    Objective: Objective: To assess deficits in social cognition among patients with Parkinson’s Disease (PD) Background: Background: Social cognition is the study of how people make…
  • « Previous Page
  • 1
  • …
  • 576
  • 577
  • 578
  • 579
  • 580
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley